Is it time to buy QBE Insurance?

It's been anything but a smooth ride for shareholders in QBE over the past few years but there could be light at the end of the tunnel.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Global insurer QBE Insurance (ASX: QBE) was recently upgraded from 'neutral' to 'outperform' by broking house Credit Suisse, which appears to hold one of the more bullish views on QBE amongst brokers who cover the stock.

With QBE's share price down from a high of $17.53 in August to $14.52 on Tuesday, it would appear to be a good time to revisit the stock. Up until early August, QBE's stock price appeared to be on the mend, with the stock outperforming the S&P/ASX 200 Index (Index: ^AXJO) (ASX: XJO) over the preceding 12 months, however the recent retraction in the share price means the current one-year share price performance of QBE is a rise of just 9.3% compared with the index which is up 21%.

Even more dramatic is the significant underperformance over the past three months, which has seen QBE's share price record a 10.3% fall, while the index has climbed 7.3%. There are at least two factors which have influenced the recent underperformance.

Firstly, QBE has been seen as a 'play' on the weakening Australian dollar due to its significant global operations and foreign currency earnings. However with the Australian dollar strengthening by 3% in the past three months this foreign exchange momentum has been weakened.

Secondly, the half-yearly result announced in mid-August (QBE has a December year-end) disappointed investors — particularly the weak results from the North American division and also the board's decision to cut the dividend.

QBE hasn't been alone in its underperformance over the past three months. The other major insurers, Insurance Australia Group (ASX: IAG) and Suncorp (ASX: SUN), have both also underperformed the S&P/ASX 200 Index over this timeframe. However their performance over the past 12 months is exceptional with IAG and Suncorp's shares up 31.7% and 40.6% respectively.

Foolish takeaway

QBE does face a unique set of challenges largely due to its heritage of acquisitive growth, which has left the insurer with a sprawling empire of businesses across the globe. Under the guidance of recently installed CEO John Neal, QBE is successfully implementing a transformation program which should leave the insurer leaner, more efficient and with annual cost savings of over $250 million.

Motley Fool contributor Tim McArthur owns shares in QBE Insurance.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »